GlassScriptPhysician profile
Anna M Seeley
NPI 1558783290
$4,544.01
in general payments reported to CMS, 2019-2025
27 companies · $2,091 in 2025
The $2,091 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $490 · 2023: $1,104 · 2024: $859 · 2025: $2,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859 · Travel and Lodging: $746 · Education: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,859.03 |
| Travel and Lodging | $746.22 |
| Education | $448.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,380.75 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $839.49 | 2022-2025 | Fasenra, Breztri, Airsupra |
| Grifols USA, LLC | $280.69 | 2022-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $265.79 | 2022-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $232.39 | 2023-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $219.17 | 2022-2024 | |
| Amgen INC. | $184.38 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.85 | 2022-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Sanofi-Aventis U.S. LLC | $156.47 | 2023-2025 | |
| Genzyme Corporation | $132.97 | 2022-2025 | |
| Astellas Pharma US INC | $89.99 | 2023 | |
| United Therapeutics Corporation | $79.39 | 2022-2025 | Remodulin, Orenitram |
| Verona Pharma, INC. | $77.28 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $61.12 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Glaxosmithkline, LLC. | $44.13 | 2022-2025 | Nucala |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $43.71 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $41.73 | 2024-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $36.09 | 2023 | Glassia |
| Azurity Pharmaceuticals, INC. | $33.23 | 2024 | Horizant |
| Philips North America LLC | $29.31 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $28.30 | 2024 | Lumryz |
| Axsome Therapeutics, INC. | $28.08 | 2022-2023 | Sunosi |
| Sanofi Pasteur INC. | $20.07 | 2023 | |
| Mallinckrodt Hospital Products INC. | $15.05 | 2024 | Acthar |
| Pfizer INC. | $14.97 | 2024 | |
| Electromed, INC. | $14.54 | 2025 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Seeley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.